Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Davis

Showing results (361-370 of 391) with videos related to

Pageof 40
Sort By:
Histopathology|September 19, 2014
Gleason drift in the NIHR ProtecT studyJon Oxley, Andrew Simpkin, John Goepel, et al.
BMJ Open|September 10, 2020
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trialJulia Wade, Jenny Donovan, Athene Lane, et al.
Medrxiv : the Preprint Server for Health Sciences|April 12, 2024
The aconitate decarboxylase 1/itaconate pathway modulates immune dysregulation and associates with cardiovascular disease markers in SLEEduardo Patiño-Martinez, Shuichiro Nakabo, Kan Jiang, et al.
NPJ Digital Medicine|September 29, 2024
Blending space and time to talk about cancer in extended realityTamsin J Robb, Yinan Liu, Braden Woodhouse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2024
The Aconitate Decarboxylase 1/Itaconate Pathway Modulates Immune Dysregulation and Associates with Cardiovascular Disease Markers and Disease Activity in Systemic Lupus ErythematosusEduardo Patiño-Martinez, Shuichiro Nakabo, Kan Jiang, et al.
Advanced Healthcare Materials|February 24, 2026
Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding MaterialsRajesh Mukthavaram, Steven P Tanis, Amit Sagi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysisSimon M Collin, Chris Metcalfe, Helga Refsum, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026
Multi-omic profiling reveals immune cell priming signature linked to lupus prognosisMichael A Smith, Dominic Sinibaldi, Saifur Rahman, et al.
The New England Journal of Medicine|September 15, 2016
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
BJU International|January 5, 2020
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progressionRichard J Bryant, Jon Oxley, Grace J Young, et al.
Pageof 40

Showing results (361-370 of 391) with videos related to

Sort By:
Pageof 40
Histopathology|September 19, 2014
Gleason drift in the NIHR ProtecT studyJon Oxley, Andrew Simpkin, John Goepel, et al.
BMJ Open|September 10, 2020
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trialJulia Wade, Jenny Donovan, Athene Lane, et al.
Medrxiv : the Preprint Server for Health Sciences|April 12, 2024
The aconitate decarboxylase 1/itaconate pathway modulates immune dysregulation and associates with cardiovascular disease markers in SLEEduardo Patiño-Martinez, Shuichiro Nakabo, Kan Jiang, et al.
NPJ Digital Medicine|September 29, 2024
Blending space and time to talk about cancer in extended realityTamsin J Robb, Yinan Liu, Braden Woodhouse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2024
The Aconitate Decarboxylase 1/Itaconate Pathway Modulates Immune Dysregulation and Associates with Cardiovascular Disease Markers and Disease Activity in Systemic Lupus ErythematosusEduardo Patiño-Martinez, Shuichiro Nakabo, Kan Jiang, et al.
Advanced Healthcare Materials|February 24, 2026
Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding MaterialsRajesh Mukthavaram, Steven P Tanis, Amit Sagi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysisSimon M Collin, Chris Metcalfe, Helga Refsum, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026
Multi-omic profiling reveals immune cell priming signature linked to lupus prognosisMichael A Smith, Dominic Sinibaldi, Saifur Rahman, et al.
The New England Journal of Medicine|September 15, 2016
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerFreddie C Hamdy, Jenny L Donovan, J Athene Lane, et al.
BJU International|January 5, 2020
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progressionRichard J Bryant, Jon Oxley, Grace J Young, et al.
Pageof 40